Matrine Inhibited Viability, Oxidative Stress, and Inflammation of Colon Cancer Cells by Activating the Nuclear Factor Erythroid 2-Related Factor 2 Pathway. The gene discussed is NFE2L2; the disease is malignant colon neoplasm.